Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 48

Results For "UK"

991 News Found

Lupin receives USFDA approval for Allopurinol Tablets
Drug Approval | December 17, 2023

Lupin receives USFDA approval for Allopurinol Tablets

The product will be manufactured at Lupin's Pithampur facility in India


INEOS Styrolution’s NAS Eco cuts CO2 emissions by 93% in healthcare application
Sustainability | December 03, 2023

INEOS Styrolution’s NAS Eco cuts CO2 emissions by 93% in healthcare application

The new ECO grade is made using renewable feedstock


New global survey finds widespread misunderstandings about shingles despite its lifetime prevalence
News | December 01, 2023

New global survey finds widespread misunderstandings about shingles despite its lifetime prevalence

A new GSK survey shows a large number of adults do not understand how shingles may be triggered


DxVx plans to make a license-in agreement of OVM-200
News | November 25, 2023

DxVx plans to make a license-in agreement of OVM-200

Final stage in licensing OVM-200 from Oxford Vacmedix in the UK


Mandaviya visits Jan Aushadhi stall at IITF
News | November 21, 2023

Mandaviya visits Jan Aushadhi stall at IITF

Jan Ausahdhi exhibited demonstration stall during 42nd India International Trade Fair to spread awareness


Mandaviya visits Ayushman Bhav Health Pavilion at the 42nd IITF 2023
News | November 21, 2023

Mandaviya visits Ayushman Bhav Health Pavilion at the 42nd IITF 2023

Distributes Ayushman cards to several beneficiaries


Health Minister Mandaviya delivers keynote address 2nd Voice of Global South Summit 2023
Policy | November 20, 2023

Health Minister Mandaviya delivers keynote address 2nd Voice of Global South Summit 2023

Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure


Imfinzi plus chemotherapy approved in China as for metastatic biliary tract cancer
Drug Approval | November 16, 2023

Imfinzi plus chemotherapy approved in China as for metastatic biliary tract cancer

Approval based on results from TOPAZ-1 global Phase III trial and a Chinese patient


Marksans Pharma posts Q2 FY24 consolidated PAT at Rs. 82.7 Cr
News | November 13, 2023

Marksans Pharma posts Q2 FY24 consolidated PAT at Rs. 82.7 Cr

US business grew by +12.8% YoY


Aragen setting up a US$ 30 million bio-manufacturing site in Bengaluru
Biotech | October 31, 2023

Aragen setting up a US$ 30 million bio-manufacturing site in Bengaluru

Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution